Xolair 75 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FAZBC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,321
Award facts
- Contract value 100% obligated
- $2,321.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,321.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 75 mg/0.5 mL syringes. The contract, issued on October 22, 2025, with an ultimate completion date of November 13, 2025, operates under a firm fixed-price structure with no set-aside designation. DMS Pharmaceutical Group Inc. competes directly against other vendors in unrestricted federal procurement, demonstrating its competitive capability within the broader pharmaceutical supply market.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The underlying IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, encompassing a 30-month base period with three 30-month option periods. As a regional prime vendor contractor within the $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations globally, positioning the company as a critical supplier within the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FAZBC?
SPE2DB26FAZBC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FAZBC worth?
The government has obligated $2,321 on SPE2DB26FAZBC.
Is contract SPE2DB26FAZBC an order under another contract?
Yes. SPE2DB26FAZBC is a delivery order under SPE2DB24D9222, an indefinite delivery contract.
Was contract SPE2DB26FAZBC competed?
The extent of competition for SPE2DB26FAZBC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award